ASAP2
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2
Also known as: ASAP2_HUMAN, CENTB3, DDEF2, KIAA0400, PAP, SHAG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43150
- Gene
- ASAP2
- Ensembl
- ENSG00000151693
- Chromosome
- 2
- Canonical length
- 1006 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a multidomain protein containing an N-terminal alpha-helical region with a coiled-coil motif, followed by a pleckstrin homology (PH) domain, an Arf-GAP domain, an ankyrin homology region, a proline-rich region, and a C-terminal Src homology 3 (SH3) domain. The protein localizes in the Golgi apparatus and at the plasma membrane, where it colocalizes with protein tyrosine kinase 2-beta (PYK2). The encoded protein forms a stable complex with PYK2 in vivo. This interaction appears to be mediated by binding of its SH3 domain to the C-terminal proline-rich domain of PYK2. The encoded protein is tyrosine phosphorylated by activated PYK2. It has catalytic activity for class I and II ArfGAPs in vitro, and can bind the class III Arf ARF6 without immediate GAP activity. The encoded protein is believed to function as an ARF GAP that controls ARF-mediated vesicle budding when recruited to Golgi membranes. In addition, it functions as a substrate and downstream target for PYK2 and SRC, a pathway that may be involved in the regulation of vesicular transport. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008]
Canonical amino-acid sequenceUniProt
1006 residues, UniProt reviewed canonical sequence.
>O43150|ASAP2
1 MPDQISVSEF VAETHEDYKA PTASSFTTRT AQCRNTVAAI EEALDVDRMV LYKMKKSVKA
61 INSSGLAHVE NEEQYTQALE KFGGNCVCRD DPDLGSAFLK FSVFTKELTA LFKNLIQNMN
121 NIISFPLDSL LKGDLKGVKG DLKKPFDKAW KDYETKITKI EKEKKEHAKL HGMIRTEISG
181 AEIAEEMEKE RRFFQLQMCE YLLKVNEIKI KKGVDLLQNL IKYFHAQCNF FQDGLKAVES
241 LKPSIETLST DLHTIKQAQD EERRQLIQLR DILKSALQVE QKEDSQIRQS TAYSLHQPQG
301 NKEHGTERNG SLYKKSDGIR KVWQKRKCSV KNGFLTISHG TANRPPAKLN LLTCQVKTNP
361 EEKKCFDLIS HDRTYHFQAE DEQECQIWMS VLQNSKEEAL NNAFKGDDNT GENNIVQELT
421 KEIISEVQRM TGNDVCCDCG APDPTWLSTN LGILTCIECS GIHRELGVHY SRMQSLTLDV
481 LGTSELLLAK NIGNAGFNEI MECCLPAEDS VKPNPGSDMN ARKDYITAKY IERRYARKKH
541 ADNAAKLHSL CEAVKTRDIF GLLQAYADGV DLTEKIPLAN GHEPDETALH LAVRSVDRTS
601 LHIVDFLVQN SGNLDKQTGK GSTALHYCCL TDNAECLKLL LRGKASIEIA NESGETPLDI
661 AKRLKHEHCE ELLTQALSGR FNSHVHVEYE WRLLHEDLDE SDDDMDEKLQ PSPNRREDRP
721 ISFYQLGSNQ LQSNAVSLAR DAANLAKEKQ RAFMPSILQN ETYGALLSGS PPPAQPAAPS
781 TTSAPPLPPR NVGKVQTASS ANTLWKTNSV SVDGGSRQRS SSDPPAVHPP LPPLRVTSTN
841 PLTPTPPPPV AKTPSVMEAL SQPSKPAPPG ISQIRPPPLP PQPPSRLPQK KPAPGADKST
901 PLTNKGQPRG PVDLSATEAL GPLSNAMVLQ PPAPMPRKSQ ATKLKPKRVK ALYNCVADNP
961 DELTFSEGDV IIVDGEEDQE WWIGHIDGDP GRKGAFPVSF VHFIADLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- testis: 44 nTPM
- stomach: 23 nTPM
- kidney: 22 nTPM
- thyroid gland: 18 nTPM
- colon: 17 nTPM
- blood vessel: 16 nTPM
Single-cell type
- renal connecting tubule cells: 618 nCPM
- lactotrophs: 535 nCPM
- somatotrophs: 527 nCPM
- distal convoluted tubule cells: 464 nCPM
- thyrotrophs: 358 nCPM
- platelets: 356 nCPM
Immune cell
- basophil: 2.7 nTPM
- plasmacytoid DC: 0.3 nTPM
- myeloid DC: 0.1 nTPM
- total PBMC: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- basal ganglia: 47 nTPM
- cerebellum: 45 nTPM
- pons: 41 nTPM
- cerebral cortex: 41 nTPM
- hypothalamus: 38 nTPM
- white matter: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.37
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Arf GTPase activating protein
- SH3 domain
- Pleckstrin homology domain
- Ankyrin repeat
- BAR domain
- PH-like domain superfamily
- AH/BAR domain superfamily
- SH3-like domain superfamily
- Ankyrin repeat-containing domain superfamily
- ARFGAP/RecO-like zinc finger
- ASAP, PH domain
- ArfGAP domain superfamily
- Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein
- PH domain
- Putative GTPase activating protein for Arf
- Ankyrin repeats (3 copies)
- Variant SH3 domain
- BAR domain of APPL family
- ASAP2, SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ASAP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASAP2 as an antibody target. Whether an autoantibody or antibody against ASAP2 could matter depends on whether native ASAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASAP2 is annotated at the cell surface, where native ASAP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ASAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...